ONESOURCE — Onesource Specialty Pharma Balance Sheet
0.000.00%
- IN₹182.12bn
- IN₹187.79bn
- IN₹1.72bn
Annual balance sheet for Onesource Specialty Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | |
---|---|---|
Period Length: | — | — |
Source: | ARS | ARS |
Standards: | IAS | IAS |
Status: | Final | Final |
Cash | ||
Cash and Equivalents | ||
Short Term Investments | ||
Cash and Short Term Investments | 843 | 761 |
Net Total Accounts Receivable | ||
Net Total Receivables | 65.3 | 744 |
Total Inventory | ||
Prepaid Expenses | ||
Total Current Assets | 2,284 | 1,764 |
Gross Property, Plant And Equipment | ||
Accumulated Depreciation | ||
Net Property, Plant And Equipment | 13,581 | 7,252 |
Net Intangible Assets | ||
Long Term Investments | ||
Long Term Notes Receivable | ||
Other Long Term Assets | ||
Total Assets | 20,088 | 13,086 |
Accounts Payable | ||
Accrued Expenses | ||
Notes Payable / Short Term Debt | ||
Current Portion of Long Term Debt / Capital Leases | ||
Total Other Current Liabilities | ||
Total Current Liabilities | 8,652 | 6,306 |
Long Term Debt | ||
Capital Lease Obligations | ||
Total Long Term Debt | ||
Total Debt | ||
Total Other Liabilities | ||
Total Funded Status | ||
Total Liabilities | 12,234 | 9,129 |
Common Stock | ||
Additional Paid In Capital | ||
Retained Earnings (Accumulated Deficit) | ||
Total Equity | 7,855 | 3,957 |
Total Liabilities & Shareholders' Equity | 20,088 | 13,086 |
Total Common Shares Outstanding |